Literature DB >> 19837692

Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas.

Rajeev M Nepal1, Li Tong, Blerta Kolaj, Winfried Edelmann, Alberto Martin.   

Abstract

C-Myc is one of the most common targets of genetic alterations in human cancers. Although overexpression of c-Myc in the B cell compartment predisposes to lymphomas, secondary mutations are required for disease manifestation. In this article, we show that genetic deficiencies causing arrested B cell development and accumulation of B cell progenitors lead to accelerated lymphomagenesis in Emu c-myc transgenic mice. This result suggests that B cell progenitors are more prone than their mature counterparts to developing secondary oncogenic lesions that complement c-Myc in promoting transformation. To investigate the nature of these oncogenic lesions, we examined Emu c-myc mice deficient in mismatch repair function. We report that Msh2(-/-) Emu c-myc and Msh2(G674A/G674A) Emu c-myc mice rapidly succumb to pro-B cell stage lymphomas, indicating that Msh2-dependent mismatch repair function actively suppresses c-Myc-associated oncogenesis during early B cell development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837692      PMCID: PMC2773990          DOI: 10.1073/pnas.0905965106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 2.  The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.

Authors:  R Fishel
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

3.  The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice.

Authors:  Rebecca A Gladdy; Michael D Taylor; Christine J Williams; Ildiko Grandal; Jana Karaskova; Jeremy A Squire; James T Rutka; Cynthia J Guidos; Jayne S Danska
Journal:  Cancer Cell       Date:  2003-01       Impact factor: 31.743

4.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro-B cells in P53-deficient mouse bone marrow.

Authors:  L Lu; D Lejtenyi; D G Osmond
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

Review 6.  Biochemistry and genetics of eukaryotic mismatch repair.

Authors:  R Kolodner
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

7.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

Authors:  P Mombaerts; A R Clarke; M A Rudnicki; J Iacomini; S Itohara; J J Lafaille; L Wang; Y Ichikawa; R Jaenisch; M L Hooper
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

8.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max.

Authors:  B Amati; S Dalton; M W Brooks; T D Littlewood; G I Evan; H Land
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  6 in total

1.  Msh6 protects mature B cells from lymphoma by preserving genomic stability.

Authors:  Jonathan U Peled; Rani S Sellers; Maria D Iglesias-Ussel; Dong-Mi Shin; Cristina Montagna; Chunfang Zhao; Ziqiang Li; Winfried Edelmann; Herbert C Morse; Matthew D Scharff
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

2.  ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

Authors:  J Ludovic Croxford; Melissa Li Fang Tang; Meng Fei Pan; Caleb Weihao Huang; Neha Kamran; Cindy Meow Ling Phua; Wee Joo Chng; Siok Bian Ng; David H Raulet; Stephan Gasser
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

3.  Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion, and altered sensory function in mice.

Authors:  Barthelemy Diouf; Prakash Devaraju; Laura J Janke; Yiping Fan; Sharon Frase; Donnie Eddins; Jennifer L Peters; Jieun Kim; Deqing Pei; Cheng Cheng; Stanislav S Zakharenko; William E Evans
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

4.  Reduction of Prep1 levels affects differentiation of normal and malignant B cells and accelerates Myc driven lymphomagenesis.

Authors:  Giorgio Iotti; Stefania Mejetta; Livia Modica; Dmitry Penkov; Maurilio Ponzoni; Francesco Blasi
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

5.  Challenging perspectives on the cellular origins of lymphoma.

Authors:  Tim I M Malcolm; Daniel J Hodson; Elizabeth A Macintyre; Suzanne D Turner
Journal:  Open Biol       Date:  2016-09       Impact factor: 6.411

6.  Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.

Authors:  Ekta Khattar; Kyaw Ze Ya Maung; Chen Li Chew; Arkasubhra Ghosh; Michelle Meng Huang Mok; Pei Lee; Jun Zhang; Wei Hong Jeff Chor; Gökhan Cildir; Chelsia Qiuxia Wang; Nur Khairiah Mohd-Ismail; Desmond Wai Loon Chin; Soo Chin Lee; Henry Yang; Yong-Jae Shin; Do-Hyun Nam; Liming Chen; Alan Prem Kumar; Lih Wen Deng; Masahito Ikawa; Jayantha Gunaratne; Motomi Osato; Vinay Tergaonkar
Journal:  Nat Commun       Date:  2019-12-13       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.